Skip to main content
SINPHAR logo

SINPHAR — Investor Relations & Filings

Ticker · 1734 ISIN · TW0001734002 TW Manufacturing
Filings indexed 1,611 across all filing types
Latest filing 2021-08-16 Regulatory Filings
Country TW Taiwan
Listing TW 1734

About SINPHAR

www.sinphar.com

Sinphar Pharmaceutical Co., Ltd. is a vertically integrated pharmaceutical group specializing in the research, development, manufacturing, and distribution of therapeutic medicines, nutraceuticals, and medical cosmetics. Established in 1977, the company produces a diverse range of products, including Western and Chinese pharmaceuticals, specialized oncology drugs, and health supplements. Sinphar operates advanced R&D facilities and an ISO 17025-certified laboratory, leveraging high-precision technology for product innovation and quality assurance. Its business model encompasses proprietary brand management alongside professional OEM and ODM services for international markets. Key areas of expertise include the development of cancer treatments, functional health foods, and medical-grade skincare. Through its global marketing network and dedicated retail counters, Sinphar provides comprehensive healthcare solutions focused on life, health, and technology.

Recent filings

Filing Released Lang Actions
110年第2季大陸投資
Regulatory Filings Classification · 95% confidence The document is a detailed tabular disclosure of investment amounts, investment methods, and related financial figures concerning the company's investments in mainland China. It includes notes explaining the investment methods, recognition of investment gains or losses, and regulatory limits. The document is relatively short (1497 characters) and appears to be a regulatory disclosure of investment information rather than a full financial report or earnings release. It does not contain comprehensive financial statements or management discussion but rather specific regulatory-required investment data. This type of document fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2021-08-16 Chinese
110年第2季現金流量表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated cash flow statement for the period from January 1 to June 30, 2021 (110年第2季 in the Taiwanese calendar). It includes detailed financial data such as cash flows from operating, investing, and financing activities, with specific amounts and accounting items. The presence of actual financial statements for a half-year period indicates this is a comprehensive interim financial report. The document length is 2460 characters, which is relatively short but contains substantive financial data, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2021-08-13 Chinese
110年第2季綜合損益表
Interim / Quarterly Report Classification · 95% confidence The document contains detailed consolidated income statement data for the second quarter and half-year periods of the fiscal year 110 (which corresponds to 2021 in the Taiwanese calendar). It includes comprehensive financial figures such as revenue, costs, expenses, profit/loss, and earnings per share. The presence of actual financial statements and substantive financial data for a period shorter than a full fiscal year indicates this is a quarterly or interim financial report. The document length is 3740 characters, which is relatively short but contains detailed financial data, so it is not merely an announcement or a certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2021-08-13 Chinese
110年第2季資產負債表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated balance sheet with detailed financial data for multiple periods, including specific asset, liability, and equity line items. The data is presented for the second quarter of the 110th year (likely referring to a fiscal quarter) and includes comparative figures from previous periods. The document length is 4011 characters, which is relatively short but contains substantive financial data rather than just an announcement or a link to a report. The presence of detailed financial statements for a quarter indicates this is an Interim / Quarterly Report rather than an Annual Report or a simple announcement. There is no indication that this is a certification, proxy, or other type of filing. Therefore, the document is best classified as an Interim / Quarterly Report (IR).
2021-08-13 Chinese
110年第2季權益變動表
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial data specifically a consolidated statement of changes in equity for the first half of the year 110 (which corresponds to 2021 in the ROC calendar). It includes line items such as common stock, capital surplus, legal reserve, special reserve, undistributed earnings, and other equity components. The data is presented for the current period and the same period last year, indicating a comprehensive financial report for a half-year period. The document length is 4197 characters, which is sufficient to contain substantive financial data rather than just an announcement. There is no indication that this is an announcement or a certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR), as it provides comprehensive financial data for a period shorter than a full fiscal year (half-year).
2021-08-13 Chinese
公告本公司董事會決議資本公積發放現金基準日
Notice of Dividend Amount Classification · 95% confidence The document is a short announcement (678 characters) from a listed company (1734 杏輝) regarding the board resolution on the cash distribution from capital surplus, including key dates such as ex-dividend date, record date, and payment date. It does not contain financial statements or detailed financial analysis but rather dividend-related information. This fits the definition of a Notice of Dividend Amount (DIV) filing, which announces dividend amounts, payment dates, and related details to shareholders.
2021-08-12 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.